Predictors of infarct artery patency after prehospital thrombolysis: the multicentre, prospective, observational OPTIMAL study

被引:7
作者
Bongard, V. [1 ]
Puel, J. [2 ]
Savary, D. [3 ]
Belle, L. [4 ]
Charpentier, S. [5 ]
Cottin, Y. [6 ]
Soulat, L. [7 ]
Elbaz, M. [2 ]
Miljkovic, D. [8 ]
Steg, Ph G. [9 ]
机构
[1] Univ Toulouse, CHU Toulouse, Fac Med, Dept Epidemiol, F-31073 Toulouse, France
[2] CHU Toulouse, Dept Cardiol, Toulouse, France
[3] Ctr Hosp Annecy, SAMU 74, Annecy, France
[4] Ctr Hosp Annecy, Dept Cardiol, Annecy, France
[5] CHU Toulouse, Dept Emergency, Toulouse, France
[6] CHU Dijon, Dept Cardiol, Dijon, France
[7] Ctr Hosp Chateauroux, Ctr SAMU SMUR 15, Chateauroux, France
[8] Boehringer Ingelheim GmbH & Co KG, Reims, France
[9] Univ Paris 07, INSERM, Dept Cardiol, AP HP,U698, Paris, France
关键词
ACUTE MYOCARDIAL-INFARCTION; PRIMARY ANGIOPLASTY; THERAPY; FIBRINOLYSIS; TRIAL; MORTALITY; ABCIXIMAB; EFFICACY; SMOKING; REGIMEN;
D O I
10.1136/hrt.2008.152504
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To identify predictors of early TIMI 3 flow patency of the infarct-related artery after prehospital thrombolysis in patients with ST-segment elevation myocardial infarction (STEMI) using data from a "real-world'' population, and to develop a nomogram for triaging patients to emergency angiography. Design: Multicentre, observational, prospective, cohort study. Setting: 79 Hospitals in France with a prehospital mobile intensive care unit and a coronary care unit with 24 h access to coronary angiography. Patients: 997 Patients with STEMI. Interventions: All patients received prehospital thrombolysis within 6 h of symptom onset and angiography was performed within 6 h of thrombolysis. Main outcome measures: Coronary patency (TIMI flow). Results: The median age of the population was 59 years and the sample comprised 18% women. After multivariable logistic regression analysis, predictors of TIMI 3 flow in the infarct-related artery were current/previous smoking (odds ratio (OR) = 1.60, 95% confidence interval 1.15 to 2.22), (5 leads with ST-segment elevation before thrombolysis (OR = 1.59, 1.12 to 2.25), Killip class I (OR = 1.96, 1.05 to 3.67), chest pain relief (OR = 1.62, 1.17 to 2.25) and ST-segment resolution >= 70% (OR = 1.76, 1.29 to 2.38). A nomogram was developed to assess the probability of TIMI 3 flow, according to smoking status, number of leads with ST elevation before thrombolysis, Killip class, chest pain relief and ST-segment resolution. Conclusions: This study provides quantitative data for predicting success of prehospital thrombolysis. The nomogram is a simple tool for predicting likelihood of coronary patency, based on clinical and electrocardiographic data. It may help to identify patients who require emergency angiography and rescue percutaneous coronary intervention.
引用
收藏
页码:799 / U35
页数:9
相关论文
共 32 条
[1]  
[Anonymous], 1986, LANCET, V1, P397
[2]   Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction - Insights from TIMI 14 and InTIME-II [J].
Antman, EM ;
Cooper, HA ;
Gibson, CM ;
de Lemos, JA ;
McCabe, CH ;
Giugliano, RP ;
Coussement, P ;
Murphy, S ;
Scherer, J ;
Anderson, K ;
Van de Werf, F ;
Braunwald, E .
EUROPEAN HEART JOURNAL, 2002, 23 (12) :928-933
[3]   INDICATIONS FOR FIBRINOLYTIC THERAPY IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - COLLABORATIVE OVERVIEW OF EARLY MORTALITY AND MAJOR MORBIDITY RESULTS FROM ALL RANDOMIZED TRIALS OF MORE THAN 1000 PATIENTS [J].
APPLEBY, P ;
BAIGENT, C ;
COLLINS, R ;
FLATHER, M ;
PARISH, S ;
PETO, R ;
BELL, P ;
HALLS, H ;
MEAD, G ;
DIAZ, R ;
PAOLASSO, E ;
PAVIOTTI, C ;
ROMERO, G ;
CAMPBELL, T ;
OROURKE, MF ;
THOMPSON, P ;
LESAFFRE, E ;
VANDEWERF, F ;
VERSTRAETE, M ;
ARMSTRONG, PW ;
CAIRNS, JA ;
MORAN, C ;
TURPIE, AG ;
YUSUF, S ;
GRANDE, P ;
HEIKKILA, J ;
KALA, R ;
BASSAND, JP ;
BOISSEL, JP ;
BROCHIER, M ;
LEIZOROVICZ, A ;
BRUGGEMANN, T ;
KARSCH, KR ;
KASPER, W ;
LAMMERTS, D ;
NEUHAUS, KL ;
MEYER, J ;
SCHRODER, R ;
VONESSEN, R ;
SARAN, RK ;
ARDISSINO, D ;
BONADUCE, D ;
BRUNELLI, C ;
CERNIGLIARO, C ;
FORESTI, A ;
FRANZOSI, MG ;
GUIDUCCI, D ;
MAGGIONI, A ;
MAGNANI, B ;
MATTIOLI, G .
LANCET, 1994, 343 (8893) :311-322
[4]   EVALUATION OF PARADOXIC BENEFICIAL-EFFECTS OF SMOKING IN PATIENTS RECEIVING THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION - MECHANISM OF THE SMOKERS PARADOX FROM THE GUSTO-I TRIAL, WITH ANGIOGRAPHIC INSIGHTS [J].
BARBASH, GI ;
REINER, J ;
WHITE, HD ;
WILCOX, RG ;
ARMSTRONG, PW ;
SADOWSKI, Z ;
MORRIS, D ;
AYLWARD, P ;
WOODLIEF, LH ;
TOPOL, EJ ;
CALIFF, RM ;
ROSS, AM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (05) :1222-1229
[5]  
Belle L, 2006, ARCH MAL COEUR VAISS, V99, P823
[6]   Early thrombolytic treatment in acute myocardial infarction: Reappraisal of the golden hour [J].
Boersma, E ;
Maas, ACP ;
Deckers, JW ;
Simoons, ML .
LANCET, 1996, 348 (9030) :771-775
[7]   Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study [J].
Bonnefoy, E ;
Lapostolle, F ;
Leizorovicz, A ;
Steg, G ;
McFadden, EP ;
Dubien, PY ;
Cattan, S ;
Boullenger, E ;
Machecourt, J ;
Lacroute, JM ;
Cassagnes, J ;
Dissait, F ;
Touboul, P .
LANCET, 2002, 360 (9336) :825-829
[8]  
Cantor W, 2008, 57 ANN SCI SESS AM C
[9]   Rationale and design of the trial of routine angioplasty and stenting after fibrinolysis to enhance reperfusion in acute myocardial infarction (TRANSFER-AMI) [J].
Cantor, Warren J. ;
Fitchett, David ;
Borgundvaag, Bjug ;
Heffernan, Michael ;
Cohen, Eric A. ;
Morrison, Laurie J. ;
Langer, Anatoly ;
Mehta, Shamir ;
Lazzam, Charles ;
Schwartz, Brian ;
Dzavik, Vladimir ;
Goodman, Shaun G. .
AMERICAN HEART JOURNAL, 2008, 155 (01) :19-25
[10]   Minimal ST-segment deviation: A simple, noninvasive method for identifying patients with a patent infarction-related artery after fibrinolytic administration [J].
Cooper, HA ;
de Lemos, JA ;
Morrow, DA ;
Sabatine, MS ;
Murphy, SA ;
McCabe, CH ;
Gibson, CM ;
Antman, EM ;
Braunwald, E .
AMERICAN HEART JOURNAL, 2002, 144 (05) :790-795